Loading organizations...
Loading organizations...
Biotech company developing immune-modulating therapeutics for cancer.
Fuse Biotherapeutics has raised $9.5M across 1 funding round.
Fuse Biotherapeutics has raised $9.5M in total across 1 funding round.
Fuse Biotherapeutics has raised $9.5M in total across 1 funding round.
Fuse Biotherapeutics's investors include GC&H Investments, Ivy Venture Group, Darren Cai, Sirona Capital.
Fuse Biotherapeutics has raised $9.5M across 1 funding round. Most recently, it raised $9.5M Seed in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 30, 2021 | $9.5M Seed | GC&H Investments, Ivy Venture Group, Darren Cai, Sirona Capital |